Clinical Study

Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 Tachyphylaxis

Table 1

Baseline characteristics of patients.

Parameters

N (male/female)15 (12/3)
Duration (years) 14.9 ± 9.2
Age (years) 59.9 ± 10.0
BMI (kg/m2)24.4 ± 3.9
SBP (mmHg)129.6 ± 12.8
DBP (mmHg)76.7 ± 14.8
HbA1c (%) 8.0 ± 0.9
LDL-C (mg/dL)99.7 ± 24.8
Insulin dosages (U)11.7 ± 4.5

Data are shown as mean ± SD.
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure.
HbA1c is presented as National Glycohemoglobin Standardization Program (NGSP) value.